Pediatric transplantation · 2025
Successful Liver Transplantation for Coats Plus Syndrome With Hepatopulmonary Syndrome: A Case Report and Literature Review.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kojima Masato, Sakamoto Seisuke, Uchida Hajime, Yanagi Yusuke, Oshiro Ayane, Fujimoto Takumi, Komine Ryuji, Zavala Edgar Antonio Murillo, Fukuda Akinari, Kasahara Mureo
Аннотация
BACKGROUND: Coats plus syndrome (CPS) is a rare telomere biology disorder (TBD) linked to mutations in the CTC1-STN1-TEN1 complex and characterized by cerebroretinal microangiopathy, bone marrow failure, and liver disease, often progressing to hepatopulmonary syndrome (HPS).
CASE PRESENTATION: The case is a 16-year-old boy clinically diagnosed with CPS at age 7. He developed exertional dyspnea at 14 with 93% of resting oxygen saturation (SpO2), 70 mmHg of partial pressure of oxygen (PaO2), and 22.9 mmHg of alveolar-arterial oxygen difference (A-aDO2) under room air, prompting home oxygen therapy (HOT). Imaging and liver biopsy showed significant collateral circulation and portal vein fibrosis and dilation without cirrhosis or pulmonary fibrosis. HPS was diagnosed by positive microbubble contrast echocardiography and 15.7% of shunt fraction in pulmonary ventilation-perfusion scintigraphy. Due to the rapid progression of HPS, he underwent living-donor LT. The postoperative disease course was good, except for acute liver rejection, and the patient was discharged on postoperative day 40. One month after transplantation, echocardiography showed a negative bubble study, pulmonary scintigraphy revealed an improved shunt fraction of 10.2%, resting SpO2 under room air was 100%, and he is doing well without the recurrence of HPS.
CONCLUSIONS: Historically, LT for HPS patients with TBDs was avoided because of uncertain prognosis and potential disease progression in other organs. However, early-stage LT in TBDs may be preferable and reduce the complexity of LT. Before irreversible changes in intrapulmonary blood vessels occur, early hypoxemia monitoring and regular imaging are essential to ensure timely LT for HPS.
CASE PRESENTATION: The case is a 16-year-old boy clinically diagnosed with CPS at age 7. He developed exertional dyspnea at 14 with 93% of resting oxygen saturation (SpO2), 70 mmHg of partial pressure of oxygen (PaO2), and 22.9 mmHg of alveolar-arterial oxygen difference (A-aDO2) under room air, prompting home oxygen therapy (HOT). Imaging and liver biopsy showed significant collateral circulation and portal vein fibrosis and dilation without cirrhosis or pulmonary fibrosis. HPS was diagnosed by positive microbubble contrast echocardiography and 15.7% of shunt fraction in pulmonary ventilation-perfusion scintigraphy. Due to the rapid progression of HPS, he underwent living-donor LT. The postoperative disease course was good, except for acute liver rejection, and the patient was discharged on postoperative day 40. One month after transplantation, echocardiography showed a negative bubble study, pulmonary scintigraphy revealed an improved shunt fraction of 10.2%, resting SpO2 under room air was 100%, and he is doing well without the recurrence of HPS.
CONCLUSIONS: Historically, LT for HPS patients with TBDs was avoided because of uncertain prognosis and potential disease progression in other organs. However, early-stage LT in TBDs may be preferable and reduce the complexity of LT. Before irreversible changes in intrapulmonary blood vessels occur, early hypoxemia monitoring and regular imaging are essential to ensure timely LT for HPS.